DF
UTHR icon

DecisionPoint Financial’s United Therapeutics UTHR Stock Holding History

DecisionPoint Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Buy
2
+1
+100% +$563 ﹤0.01% 420
2026
Q1 		$593 Hold
1
– – ﹤0.01% 446
2025
Q4 		$488 Hold
1
– – ﹤0.01% 539
2025
Q3 		$439 Hold
1
– – ﹤0.01% 495
2025
Q2 		$291 Buy
+1
New +$299 ﹤0.01% 560

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

DecisionPoint Financial's UTHR Position: Q2 2026 in Review

DecisionPoint Financial increased its United Therapeutics (UTHR) stake by 100% in Q2 2026, buying an estimated $563 and bringing the position to 2 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #420.

DecisionPoint Financial first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • DecisionPoint Financial held 2 shares of United Therapeutics worth $1.09K as of Q2 2026.
  • DecisionPoint Financial bought 1 United Therapeutics share in Q2 2026, an estimated $563.
  • United Therapeutics made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #420 holding.
  • DecisionPoint Financial first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.